TITLE

Lung deposition of nebulised pentamidine in children

AUTHOR(S)
O'Doherty, M J; Thomas, S H; Gibb, D; Page, C J; Harrington, C; Duggan, C; Nunan, T O; Bateman, N T
PUB. DATE
March 1993
SOURCE
Thorax;Mar1993, Vol. 48 Issue 3, p220
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66082176

 

Related Articles

  • A trial of nebulised heparin to limit lung injury following cardiac surgery. Dixon, B.; Smith, R.; Santamaria, J. D.; Orford, N. R.; Wakefield, B. J.; Ives, K.; McKenzie, R.; Zhang, B.; Yap, C. H. // Anaesthesia & Intensive Care;2016, Vol. 44 Issue 1, p28 

    Cardiac surgery with cardiopulmonary bypass triggers an acute inflammatory response in the lungs. This response gives rise to fibrin deposition in the microvasculature and alveoli of the lungs. Fibrin deposition in the microvasculature increases alveolar dead space, while fibrin deposition in...

  • Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis. Byrne N M; Keavey P M; Perry J D; Gould F K; Spencer D A // Archives of Disease in Childhood;Aug2003, Vol. 88 Issue 8, p715 

    AIM: To examine the effectiveness of delivery of nebulised colistin by the HaloLite nebuliser compared to the Pari LC Plus in patients with cystic fibrosis. METHODS: Randomised crossover trial of 15 patients aged >6 years. Inhalation of one mega unit of colistin in 3 ml diluent, labelled with...

  • Lung deposition after inhalation with various nebulisers in preterm infants. Köhler, E; Jilg, G; Avenarius, S; Jorch, G // Archives of Disease in Childhood;Jul2008 Supplement, Vol. 93 Issue 4, pF275 

    Aim: To compare pulmonary deposition after inhalation with three different nebulisers in preterm infants under conditions relevant to practice. Methods: The relative lung deposition (bioavailability) was estimated by inhalation of the marker substance, sodium cromoglycate (SCG), and measurement...

  • Lung deposition after inhalation with various nebulisers in preterm infants. E Köhler // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jul2008, Vol. 93 Issue 4, pF275 

    AIM: To compare pulmonary deposition after inhalation with three different nebulisers in preterm infants under conditions relevant to practice. METHODS: The relative lung deposition (bioavailability) was estimated by inhalation of the marker substance, sodium cromoglycate (SCG), and measurement...

  • Pulmonary Effects of Pentamidine. Charles, M. Arthur; Hildebrandt, Paul K.; Schwarz, Marvin I.; Zieg, Robert // Annals of Internal Medicine;Jan72, Vol. 76 Issue 1, p144 

    Presents a study that examined the effect of pentamidine on rat lung in the absence of infectious disease to determine if fibrosis following pentamidine therapy drug is related. Dosage of the drug given to the rats; Absence of histological pulmonary abnormalities in rats at necropsy; Role of...

  • Nebulized Pentamidine-Induced Acute Renal Allograft Dysfunction. Prabhavalkar, Siddhesh; Masengu, Agnes; O'Rourke, Declan; Shields, Joanne; Courtney, Aisling // Case Reports in Transplantation;2013, p1 

    Acute kidney injury (AKI) is a recognised complication of intravenous pentamidine therapy. A direct nephrotoxic effect leading to acute tubular necrosis has been postulated. We report a case of severe renal allogra? dysfunction due to nebulised pentamidine. ?e patient presented with repeated...

  • Therapy of Pneumocystis Pneumonia.  // Clinical Pediatrics;Nov1977, Vol. 16 Issue 11, p1068 

    Reports on findings of a study on the use of pentamidine isethionate for the treatment of Pneumocystis pneumonia and the early stages of Gambian sleeping sickness on children in the United States. Data gathered on patients with suspected or confirmed Pneumocystis pneumonia during the first three...

  • Spacer devices for metered dose inhalers. Newman, Stephen P. // Clinical Pharmacokinetics;2004, Vol. 43 Issue 6, p349 

    Spacer devices are attachments to the mouthpieces of pressurised metered dose inhalers (pMDIs), and range from tube spacers with a volume of <50 mL to holding chambers with a volume of 750 mL. Compared with a pMDI alone, spacers minimise coordination difficulties, reduce oropharyngeal deposition...

  • Implementing equipment guidance in the community. Cox, Amanda // Paediatric Nursing;Apr2004, Vol. 16 Issue 3, p28 

    Reports on how Medical Devices Agency (MDA) guidance in Great Britain informed a redesign of the service provided to children with cystic fibrosis who use a nebulised compressor. Objectives for the improvement of the nebuliser service; Key aspect of the implementation of the MDA guidelines;...

  • Nebulisation of Receptor-Targeted Nanocomplexes for Gene Delivery to the Airway Epithelium. Manunta, Maria D. I.; McAnulty, Robin J.; Tagalakis, Aristides D.; Bottoms, Stephen E.; Campbell, Frederick; Hailes, Helen C.; Tabor, Alethea B.; Laurent, Geoffrey J.; O'Callaghan, Christopher; Hart, Stephen L. // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Background: Gene therapy mediated by synthetic vectors may provide opportunities for new treatments for cystic fibrosis (CF) via aerosolisation. Vectors for CF must transfect the airway epithelium efficiently and not cause inflammation so they are suitable for repeated dosing. The inhaled...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics